Scarica l'app Stockscreener
8.89
1.95%
0.17
Precedente Chiudi:
$8.72
Aprire:
$8.72
Volume 24 ore:
15,716
Relative Volume:
0.86
Capitalizzazione di mercato:
$80.43M
Reddito:
$27.64M
Utile/perdita netta:
$-1.04M
Rapporto P/E:
-78.19
EPS:
-0.1137
Flusso di cassa netto:
$1.22M
1 W Prestazione:
+6.47%
1M Prestazione:
+38.04%
6M Prestazione:
+41.11%
1 anno Prestazione:
+68.69%
Intervallo 1D:
$8.72
$8.9628
Intervallo di 1 settimana:
$8.26
$8.99
Portata 52W:
$4.52
$8.99
Immucell Corp Stock (ICCC) Company Profile
Nome
Immucell Corp
Settore
Industria
Telefono
(207) 878-2770
Indirizzo
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
8.89 | 80.43M | 27.64M | -1.04M | 1.22M | -0.1137 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immucell Corp Borsa (ICCC) Ultime notizie
ICCC Technical Analysis | Trend, Signals & Chart Patterns | IMMUCELL CORP (NASDAQ:ICCC) - ChartMill
Short Interest in ImmuCell Corporation (NASDAQ:ICCC) Decreases By 20.8% - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ImmuCell (NASDAQ: ICCC) outlines 2026 strategy, equity plan and pay - Stock Titan
ImmuCell (ICCC) director discloses 17,899 stock options grant details - Stock Titan
ImmuCell (NASDAQ: ICCC) director lists 17,899 stock options - Stock Titan
ImmuCell : Corporate Presentation (Investor Relations April 2026 Final) - marketscreener.com
The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCell - Zacks Investment Research
[Form 4] IMMUCELL CORP /DE/ Insider Trading Activity - Stock Titan
ImmuCell (ICCC) grants director 11,933 stock options at $7.60 - Stock Titan
Director Gloria Basse granted 11,933 ImmuCell (ICCC) stock options - Stock Titan
ImmuCell (ICCC) director Paul Wainman receives 11,933 stock options at $7.60 - Stock Titan
650K-share equity plan and officer exculpation up for vote — ImmuCell (NASDAQ: ICCC) - Stock Titan
ImmuCell (ICCC) VP Brockmann granted 5,000 incentive stock options - Stock Titan
ImmuCell (ICCC) director receives grant of 10,000 stock options - Stock Titan
ImmuCell (ICCC) director awarded 10,000 stock options at $5.49 strike - Stock Titan
ImmuCell (ICCC) director awarded 10,000 options at $5.49 exercise price - Stock Titan
ImmuCell (ICCC) director Steven Rosgen granted 10,000 stock options at $5.49 - Stock Titan
ImmuCell (ICCC) director receives 10,000 non-qualified stock options at $5.49 - Stock Titan
ImmuCell (ICCC) adds industry veterans to a smaller, more independent board - Stock Titan
ImmuCell appoints two directors, expands to 7-member board - Investing.com
ImmuCell appoints two directors, expands to 7-member board By Investing.com - Investing.com South Africa
Two animal health veterans join ImmuCell as board shrinks to 7 - Stock Titan
ImmuCell Corporation Reports 35.7% Increase in Domestic Sales for 2026 – SEC 8-K Filing Highlights - Minichart
ImmuCell reports 28% sales increase in first quarter - Investing.com
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results - The Manila Times
ImmuCell (ICCC) Q1 2026 sales jump 28.4% on Tri-Shield strength - Stock Titan
Immucell Corporation Announces Preliminary, Unaudited Sales Results for the Firs Quarter of 2026 - marketscreener.com
Published on: 2026-04-08 23:34:29 - baoquankhu1.vn
One calf-health product drove ImmuCell's 28.4% Q1 sales jump - Stock Titan
Can ImmuCell Corporation (ICCC) Stock Double in 2026 | Price at $6.34, Down 1.55%Fast Rising Stocks - Newser
IMMUCELL (ICCC) director Kathy V. Turner files initial insider Form 3 - Stock Titan
ICCC PE Ratio & Valuation, Is ICCC Overvalued - Intellectia AI
Volume Report: Will ImmuCell Corporation be affected by tariffs2026 Market Trends & Low Risk Entry Point Guides - baoquankhu1.vn
ImmuCell (NASDAQ: ICCC) boosts 2025 margins, shifts from Re‑Tain to core First Defense calf-health line - Stock Titan
ImmuCell Corporation (NASDAQ:ICCC) Short Interest Update - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving AverageHere's Why - MarketBeat
ImmuCell (NASDAQ:ICCC) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
ImmuCell (ICCC) director exercises 25,000 options and ends with 205,700 shares - Stock Titan
ImmuCell (ICCC) CEO granted 109,500 stock options with strict profit hurdle - Stock Titan
ImmuCell Corporation Files Form 8-K with SEC Detailing Corporate Information and Press Release March 2026 - Minichart
ImmuCell appoints Kathy Turner to board of directors - Investing.com
ImmuCell (NASDAQ: ICCC) names Kathy Turner to Board as Rosgen retires - Stock Titan
Former Elanco director joins ImmuCell board in calf-health push - Stock Titan
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges By GuruFocus - Investing.com Canada
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q4 2025 Earnings Call Transcript - Insider Monkey
Immucell Corp Azioni (ICCC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):